{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:10:32Z","timestamp":1777860632698,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and Development (R&D) Projects of Shanxi Province","award":["2021XM22"],"award-info":[{"award-number":["2021XM22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04755-z","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T04:45:26Z","timestamp":1774241126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of Kif15 as a potential diagnostic and prognostic biomarker in colon cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Huiming","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingwen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renkai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yipeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"21","key":"4755_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.21037\/atm.2019.07.91","volume":"7","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Sanchis-Gomar F, Lippi G. Concise update on colorectal cancer epidemiology. Ann Transl Med. 2019;7(21):609. https:\/\/doi.org\/10.21037\/atm.2019.07.91.","journal-title":"Ann Transl Med"},{"issue":"1","key":"4755_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"4755_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12893-025-02795-y","volume":"25","author":"H Wu","year":"2025","unstructured":"Wu H, Wang Y, Deng M, et al. Preoperative inflammatory markers and tumor markers in predicting lymphatic metastasis and postoperative complications in colorectal cancer: a retrospective study. BMC Surg. 2025;25(1):71. https:\/\/doi.org\/10.1186\/s12893-025-02795-y.","journal-title":"BMC Surg"},{"issue":"4","key":"4755_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2025.02.002","volume":"43","author":"WKJ Lam","year":"2025","unstructured":"Lam WKJ, Kang G, Chan CML, et al. Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma. Cancer Cell. 2025;43(4):728\u2013e7395. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.002.","journal-title":"Cancer Cell"},{"issue":"1","key":"4755_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s42003-022-03884-x","volume":"5","author":"D Sobral","year":"2022","unstructured":"Sobral D, Martins M, Kaplan S, et al. Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development. Commun Biol. 2022;5(1):937. https:\/\/doi.org\/10.1038\/s42003-022-03884-x.","journal-title":"Commun Biol"},{"issue":"1","key":"4755_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00384-024-04654-3","volume":"39","author":"H Wu","year":"2024","unstructured":"Wu H, Deng M, Xue D, et al. PD-1\/PD-L1 inhibitors for early and middle stage microsatellite high-instability and stable colorectal cancer: a review. Int J Colorectal Dis. 2024;39(1):83. https:\/\/doi.org\/10.1007\/s00384-024-04654-3.","journal-title":"Int J Colorectal Dis"},{"key":"4755_CR7","doi-asserted-by":"publisher","unstructured":"Wang X, Fang Y, Liang W et al. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell. 2024;42(10):1729\u20131746.e8. . Epub 2024 Sep 19. Erratum in: Cancer Cell. 2025;43(3):564\u2013574. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.023.","DOI":"10.1016\/j.ccell.2025.02.023"},{"issue":"7","key":"4755_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/onc.2017.406","volume":"37","author":"AJ Lucanus","year":"2018","unstructured":"Lucanus AJ, Yip GW. Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics. Oncogene. 2018;37(7):833\u20138. https:\/\/doi.org\/10.1038\/onc.2017.406.","journal-title":"Oncogene"},{"issue":"1","key":"4755_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12894-025-01732-8","volume":"25","author":"J Wang","year":"2025","unstructured":"Wang J, Lai X, Sun Z, et al. KIF14 plays a role in the regulation of the cell cycle and has implications for prognosis in clear cell renal cell carcinoma. BMC Urol. 2025;25(1):74. https:\/\/doi.org\/10.1186\/s12894-025-01732-8.","journal-title":"BMC Urol"},{"issue":"1","key":"4755_CR10","doi-asserted-by":"publisher","first-page":"21449","DOI":"10.1038\/s41598-024-72406-y","volume":"14","author":"Q Guo","year":"2024","unstructured":"Guo Q, Qiu P, Pan K, et al. Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer. Sci Rep. 2024;14(1):21449. https:\/\/doi.org\/10.1038\/s41598-024-72406-y.","journal-title":"Sci Rep"},{"issue":"1","key":"4755_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/tra.12621","volume":"20","author":"Z Dong","year":"2019","unstructured":"Dong Z, Wu S, Zhu C, et al. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)\/Cas9-mediated kif15 mutations accelerate axonal outgrowth during neuronal development and regeneration in zebrafish. Traffic. 2019;20(1):71\u201381. https:\/\/doi.org\/10.1111\/tra.12621.","journal-title":"Traffic"},{"key":"4755_CR12","doi-asserted-by":"publisher","first-page":"679173","DOI":"10.3389\/fonc.2021.679173","volume":"11","author":"L Gao","year":"2021","unstructured":"Gao L, Zhao R, Liu J, et al. KIF15 Promotes progression of castration resistant prostate cancer by activating egfr signaling pathway. Front Oncol. 2021;11:679173. https:\/\/doi.org\/10.3389\/fonc.2021.679173.","journal-title":"Front Oncol"},{"key":"4755_CR13","doi-asserted-by":"publisher","first-page":"772816","DOI":"10.3389\/fonc.2022.772816","volume":"12","author":"J Mi","year":"2022","unstructured":"Mi J, Ma S, Chen W, et al. Integrative pan-cancer analysis of KIF15 reveals its diagnosis and prognosis value in nasopharyngeal carcinoma. Front Oncol. 2022;12:772816. https:\/\/doi.org\/10.3389\/fonc.2022.772816.","journal-title":"Front Oncol"},{"issue":"10","key":"4755_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41419-020-03041-4","volume":"11","author":"Y Ma","year":"2020","unstructured":"Ma Y, Zhan S, Lu H, et al. B7-H3 regulates KIF15-activated ERK1\/2 pathway and contributes to radioresistance in colorectal cancer. Cell Death Dis. 2020;11(10):824. https:\/\/doi.org\/10.1038\/s41419-020-03041-4.","journal-title":"Cell Death Dis"},{"key":"4755_CR15","doi-asserted-by":"publisher","unstructured":"Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023 May-Jun;73(3):233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","DOI":"10.3322\/caac.21772"},{"issue":"1","key":"4755_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/s24010037","volume":"24","author":"S Das","year":"2023","unstructured":"Das S, Dey MK, Devireddy R, Gartia MR. Biomarkers in cancer detection, diagnosis, and prognosis. Sens (Basel). 2023;24(1):37. https:\/\/doi.org\/10.3390\/s24010037.","journal-title":"Sens (Basel)"},{"issue":"1","key":"4755_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1083\/jcb.200408113","volume":"167","author":"CJ Lawrence","year":"2004","unstructured":"Lawrence CJ, Dawe RK, Christie KR, et al. A standardized kinesin nomenclature. J Cell Biol. 2004;167(1):19\u201322. https:\/\/doi.org\/10.1083\/jcb.200408113.","journal-title":"J Cell Biol"},{"issue":"1","key":"4755_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12967-025-06178-y","volume":"23","author":"X Cheng","year":"2025","unstructured":"Cheng X, Zhao H, Li Z, et al. Integrative analysis of T cell-mediated tumor killing-related genes reveals KIF11 as a novel therapeutic target in esophageal squamous cell carcinoma. J Transl Med. 2025;23(1):197. https:\/\/doi.org\/10.1186\/s12967-025-06178-y.","journal-title":"J Transl Med"},{"issue":"1","key":"4755_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbadis.2018.10.039","volume":"1865","author":"Z Yang","year":"2019","unstructured":"Yang Z, Li C, Yan C, et al. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochim Biophys Acta Mol Basis Dis. 2019;1865(1):181\u201392. https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.039.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"22 Pt 1","key":"4755_CR20","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1158\/1078-0432.CCR-07-1328","volume":"13","author":"M Taniwaki","year":"2007","unstructured":"Taniwaki M, Takano A, Ishikawa N, et al. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin Cancer Res. 2007;13(22 Pt 1):6624\u201331. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1328.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4755_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/bjc.2017.165","volume":"117","author":"J Wang","year":"2017","unstructured":"Wang J, Guo X, Xie C, Jiang J. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway. Br J Cancer. 2017;117(2):245\u201355. https:\/\/doi.org\/10.1038\/bjc.2017.165.","journal-title":"Br J Cancer"},{"key":"4755_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2019.11.008","volume":"482","author":"Q Li","year":"2020","unstructured":"Li Q, Qiu J, Yang H, et al. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma. Cancer Lett. 2020;482:112\u201325. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.008.","journal-title":"Cancer Lett"},{"key":"4755_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12935-020-01199-7","volume":"20","author":"L Ding","year":"2020","unstructured":"Ding L, Li B, Yu X, et al. KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis. Cancer Cell Int. 2020;20:125. https:\/\/doi.org\/10.1186\/s12935-020-01199-7.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"4755_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, et al. An integrated tcga pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400\u2013e41611. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052","journal-title":"Cell"},{"issue":"14","key":"4755_CR25","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cub.2013.05.043","volume":"23","author":"EG Sturgill","year":"2013","unstructured":"Sturgill EG, Ohi R. Kinesin-12 differentially affects spindle assembly depending on its microtubule substrate. Curr Biol. 2013;23(14):1280\u201390. https:\/\/doi.org\/10.1016\/j.cub.2013.05.043.","journal-title":"Curr Biol"},{"issue":"20","key":"4755_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.cub.2009.09.019","volume":"19","author":"D Vanneste","year":"2009","unstructured":"Vanneste D, Takagi M, Imamoto N, et al. The role of Hklp2 in the stabilization and maintenance of spindle bipolarity. Curr Biol. 2009;19(20):1712\u20137. https:\/\/doi.org\/10.1016\/j.cub.2009.09.019.","journal-title":"Curr Biol"},{"issue":"5","key":"4755_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1042\/BST0391154","volume":"39","author":"D Vanneste","year":"2011","unstructured":"Vanneste D, Ferreira V, Vernos I. Chromokinesins: localization-dependent functions and regulation during cell division. Biochem Soc Trans. 2011;39(5):1154\u201360. https:\/\/doi.org\/10.1042\/BST0391154.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"4755_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/neuros\/nyy268","volume":"85","author":"D Pratt","year":"2019","unstructured":"Pratt D, Dominah G, Lobel G, et al. Programmed death ligand 1 is a negative prognostic marker in recurrent isocitrate dehydrogenase-wildtype glioblastoma. Neurosurgery. 2019;85(2):280\u20139. https:\/\/doi.org\/10.1093\/neuros\/nyy268.","journal-title":"Neurosurgery"},{"key":"4755_CR29","doi-asserted-by":"publisher","first-page":"1500954","DOI":"10.3389\/fimmu.2025.1500954","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Peng W, Yang W, et al. Efficacy and safety of programmed cell death protein-1 inhibitor for first-line therapy of advanced gastric or gastroesophageal junction cancer: a network meta-analysis. Front Immunol. 2025;16:1500954. https:\/\/doi.org\/10.3389\/fimmu.2025.1500954.","journal-title":"Front Immunol"},{"issue":"23","key":"4755_CR30","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1002\/cncr.32163","volume":"125","author":"S Piawah","year":"2019","unstructured":"Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139\u201347. https:\/\/doi.org\/10.1002\/cncr.32163.","journal-title":"Cancer"},{"issue":"1","key":"4755_CR31","doi-asserted-by":"publisher","first-page":"e000638","DOI":"10.1136\/esmoopen-2019-000638","volume":"5","author":"D Lau","year":"2020","unstructured":"Lau D, Kalaitzaki E, Church DN, et al. Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study. ESMO Open. 2020;5(1):e000638. https:\/\/doi.org\/10.1136\/esmoopen-2019-000638.","journal-title":"ESMO Open"},{"key":"4755_CR32","doi-asserted-by":"publisher","first-page":"101917","DOI":"10.1016\/j.eclinm.2023.101917","volume":"58","author":"M Fakih","year":"2023","unstructured":"Fakih M, Raghav KPS, Chang DZ, et al. Regorafenib plus nivolumab in patients with mismatch repair-proficient\/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study. EClinicalMedicine. 2023;58:101917. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101917.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"4755_CR33","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41416-024-02696-6","volume":"130","author":"AH Ree","year":"2024","unstructured":"Ree AH, \u0160altyt\u0117 Benth J, Hamre HM, et al. First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial. Br J Cancer. 2024;130(12):1921\u20138. https:\/\/doi.org\/10.1038\/s41416-024-02696-6.","journal-title":"Br J Cancer"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04755-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04755-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04755-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:20:29Z","timestamp":1777512029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04755-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4755"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04755-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed informed consent forms. This study was reviewed and approved by the Ethics Committee of Shanxi Medical University (2021GLL134). This study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}